FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Thank you!

Thank you for taking the time to answer our survey. You can find more information about all the ways we’re transforming the lives of people living with neuromuscular disease below:

Find MDA
in your Community